Abstract:Objective To evaluate the application value of quantitative immune fecal occult blood test (FOBT) in colonoscopy for the screening of colorectal cancer in health check-up participants. Methods The subjects were selected from July 2017 to June 2018 in the Health Management Center of the Second Affiliated Hospital of Suzhou University. The subjects were the healthy individuals who chose quantitative immune FOBT or chemical method plus immunogold double-method FOBT (referred to as"double-method FOBT"), excluding those who had interfering factors. Individuals with a positive result in primary screening were selected and conducted with colorectal cancer by colonoscopy. If the polyploidy lesions were observed during colonoscopy, the biopsy or excision was performed, and the pathological diagnosis was performed. The positive rate of primary screening, compliance rate of colonoscopy and pathological results of colonoscopy were compared between the two methods. Quantitative immunoassay FOBT was analyzed in different gender, age group, physical examination nature, positive rate of primary screening, compliance rate of colonoscopy and pathological results of colonoscopy. Results 18 728 people chose quantitative immunoassay FOBT and 6 212 people chose double-method FOBT at the same time. There was no significant difference in gender and age between the two groups (all P>0.05), which was comparable. The detection rate of quantitative immune FOBT was higher than double-method FOBT (74.62% vs 32.23%, P<0.001). The positive rate of quantitative immune FOBT in primary screening was lower than double-method FOBT (4.11% vs 5.34%, P=0.003). The colonoscopy screening rate in positive population by quantitative immune FOBT was higher than double-method FOBT (27.83% vs 13.08%, P=0.001). These differences were statistically significant. The detection rate of total lesions by colonoscopy was 71.88% in positive population by quantitative immune FOBT. It was 42.86% in double-method FOBT. There was no statistical difference between the two methods (P=0.05). The detection rates of quantitative immune FOBT were significantly different among different genders, ages and physical properties (all P<0.001). The detection rate was higher in males than in females (79.14% vs 68.75%). The detection rate was highest in the group between 40 and 59 years old (79.96%). The individual detection rate was higher than the group (90.08% vs 66.07%). The positive rates in primary screening were significantly different among different ages (P=0.001).It was highest in the group aged 60 or above (5.59%). The colonoscopy screening rate in positive population by quantitative immune FOBT was highest in the group aged 50 or above (36.96%). The detection rate of inflammatory lesions were significantly different among different ages (P<0.001). The detection rate of colorectal cancer in males was higher than in females (11.11% vs 0.00%, P=0.009). In addition, with the increasing of fecal occult blood value, the detection rate of cancer was increased (P=0.041). Conclusion The quantitative immune FOBT is an ideal non-invasive examination for early screening of colorectal cancer. It has important application values.

Comparative Study of Hypersensitive Quantitative Fecal Immunochemical Test and Qualitative Fecal Occult Blood Test for Colorectal Cancer and Advanced Adenoma

Diagnostic efficacy of hypersensitivity quantitative fecal immunochemical test in colorectal cancer and advanced adenoma

[Diagnostic Performance of Quantitative Fecal Immunochemical Test in Detection of Advanced Colorectal Neoplasia].

Head-to-head Comparison of the Test Performance of Self-Administered Qualitative Vs. Laboratory-Based Quantitative Fecal Immunochemical Tests in Detecting Colorectal Neoplasm

Comparative Evaluation of Preliminary Screening Methods for Colorectal Cancer in a Mass Program

Comparison of Guaiac-Based and Quantitative Immunochemical Fecal Occult Blood Testing in a Population at Average Risk Undergoing Colorectal Cancer Screening

Predictive Power of Quantitative and Qualitative Fecal Immunochemical Tests for Hemoglobin in Population Screening for Colorectal Neoplasm

Quantitative Immunochemical Fecal Occult Blood Testing for Colorectal Adenoma Detection: Evaluation in the Target Population of Screening and Comparison With Qualitative Tests

One-sample quantitative and two-sample qualitative faecal immunochemical tests for colorectal cancer screening: a cross-sectional study in China

Yield and Effectiveness of 2-Sample Fecal Immunochemical Test-Based Screening Program for Colorectal Cancer.

The application of quantitative immune fecal occult blood test for the screening of colorectal cancer in health check?up participants

Application of quantitative FIT for primary colorectal cancer screening of a health check-up population in Suzhou City

Comparative Performance of Common Fecal Immunochemical Tests : A Cross-Sectional Study

Optimizing Sampling Device for the Fecal Immunochemical Test Increases Colonoscopy Yields in Colorectal Cancer Screening.

Comparison Between Application of Fecal Occult Blood Quantitive Testing Instrument and Colloidal Gold Strip Method in Colorectal Cancer Screening

Diagnostic Accuracy of a Qualitative Fecal Immunochemical Test Varies with Location of Neoplasia but Not Number of Specimens

Accuracy of a faecal immunochemical test in patients under colonoscopy surveillance of colorectal adenoma and cancer

Comparative Yield and Efficiency of Strategies Based on Risk Assessment and Fecal Immunochemical Test in Colorectal Cancer Screening: A Cross-Sectional Population-Based Analysis

New Immunochemical Fecal Occult Blood Test With Two-Consecutive Stool Sample Testing Is A Cost-Effective Approach For Colon Cancer Screening: Results Of A Prospective Multicenter Study In Chinese Patients

Optimization of screening strategies for colorectal cancer based on fecal DNA and occult blood testing

Head-to-Head Diagnostic Test Accuracy Meta-analysis of Colonoscopy and Fecal Immunochemical Test in Detecting Advanced Colon Neoplasia